Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1984 Nov;81(22):7248–7252. doi: 10.1073/pnas.81.22.7248

Regional distribution of putative vasopressin receptors in rat brain and pituitary by quantitative autoradiography.

R E Brinton, K W Gee, J K Wamsley, T P Davis, H I Yamamura
PMCID: PMC392116  PMID: 6095279

Abstract

Quantitative light microscopic autoradiography was used to map and characterize the distribution of [3H]arginine vasopressin [( 3H]AVP) binding sites in the rat brain. HPLC analysis for possible degradation of AVP during binding indicated that addition of specific peptidase inhibitors prevented metabolism of AVP. Binding sites for [3H]AVP were observed in the hypothalamus and pituitary as well as in brain regions where AVP may act as a neuroregulator. Within the hypothalamus, dense AVP binding sites were seen in the suprachiasmatic, supraoptic, and paraventricular nuclei. High specific binding was also apparent in the median eminence tubero-infundibular region and in the posterior lobe of the pituitary. [3H]AVP labeling at possible neuroregulatory sites was observed in the hippocampus, lateral septum, superficial cortex, cerebellum, nucleus tractus solitarious, adenohypophysis, and spinal cord.

Full text

PDF
7249

Images in this article

7250Image
on p.7250
7250Image
on p.7250

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe H., Inoue M., Matsuo T., Ogata N. The effects of vasopressin on electrical activity in the guinea-pig supraoptic nucleus in vitro. J Physiol. 1983 Apr;337:665–685. doi: 10.1113/jphysiol.1983.sp014648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barker J. L., Gainer H. Peptide regulation of bursting pacemaker activity in a molluscan neurosecretory cell. Science. 1974 Jun 28;184(4144):1371–1373. doi: 10.1126/science.184.4144.1371. [DOI] [PubMed] [Google Scholar]
  3. Bartus R. T., Dean R. L., Beer B. Neuropeptide effects on memory in aged monkeys. Neurobiol Aging. 1982 Spring;3(1):61–68. doi: 10.1016/0197-4580(82)90062-8. [DOI] [PubMed] [Google Scholar]
  4. Baskin D. G., Petracca F., Dorsa D. M. Autoradiographic localization of specific binding sites for [3H][Arg8]vasopressin in the septum of the rat brain with tritium-sensitive film. Eur J Pharmacol. 1983 May 20;90(1):155–157. doi: 10.1016/0014-2999(83)90231-5. [DOI] [PubMed] [Google Scholar]
  5. Biegon A., Terlou M., Voorhuis T. D., de Kloet E. R. Arginine-vasopressin binding sites in rat brain: a quantitative autoradiographic study. Neurosci Lett. 1984 Feb 24;44(3):229–234. doi: 10.1016/0304-3940(84)90027-2. [DOI] [PubMed] [Google Scholar]
  6. Brinton R. E., Deshmukh P. P., Chen A., Davis T. P., Hsiao S., Yamamura H. I. A non-equilibrium 24-hour vasopressin radioimmunoassay: development and basal levels in the rat brain. Brain Res. 1983 May 5;266(2):344–347. doi: 10.1016/0006-8993(83)90667-4. [DOI] [PubMed] [Google Scholar]
  7. Brownstein M. J., Gainer H. Neurophysin biosynthesis in normal rats and in rats with hereditary diabetes insipidus. Proc Natl Acad Sci U S A. 1977 Sep;74(9):4046–4049. doi: 10.1073/pnas.74.9.4046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Buijs R. M. Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Pathways to the limbic system, medulla oblongata and spinal cord. Cell Tissue Res. 1978 Sep 26;192(3):423–435. doi: 10.1007/BF00212323. [DOI] [PubMed] [Google Scholar]
  9. Courtney N., Raskind M. Vasopressin affects adenylate cyclase activity in rat brain: a possible neuromodulator. Life Sci. 1983 Feb 7;32(6):591–596. doi: 10.1016/0024-3205(83)90203-5. [DOI] [PubMed] [Google Scholar]
  10. DOMER F. R., FELDBERG W. Scratching movements and facilitation of the scratch reflex produced by tubocurarine in cats. J Physiol. 1960 Aug;153:35–51. doi: 10.1113/jphysiol.1960.sp006517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Davis T. P., Culling A. J., Schoemaker H., Galligan J. J. beta-Endorphin and its metabolites stimulate motility of the dog small intestine. J Pharmacol Exp Ther. 1983 Nov;227(2):499–507. [PubMed] [Google Scholar]
  12. De Vries G. J., Buijs R. M. The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum. Brain Res. 1983 Aug 29;273(2):307–317. doi: 10.1016/0006-8993(83)90855-7. [DOI] [PubMed] [Google Scholar]
  13. Glick S. M., Brownstein M. J. Vasopressin content of rat brain. Life Sci. 1980 Sep 22;27(12):1103–1110. doi: 10.1016/0024-3205(80)90036-3. [DOI] [PubMed] [Google Scholar]
  14. Koob G. F., Le Moal M., Gaffori O., Manning M., Sawyer W. H., Rivier J., Bloom F. E. Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats. Regul Pept. 1981 Jun;2(3):153–163. doi: 10.1016/0167-0115(81)90009-4. [DOI] [PubMed] [Google Scholar]
  15. Kovács G. L., Bohus B., Versteeg D. H., de Kloet E. R., de Wied D. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures. Brain Res. 1979 Oct 19;175(2):303–314. doi: 10.1016/0006-8993(79)91009-6. [DOI] [PubMed] [Google Scholar]
  16. Léránth C., Záborszky L., Marton J., Palkovits M. Quantitative studies on the supraoptic nucleus in the rat. I. Synaptic organization. Exp Brain Res. 1975 May 22;22(5):509–523. doi: 10.1007/BF00237351. [DOI] [PubMed] [Google Scholar]
  17. Mühlethaler M., Dreifuss J. J., Gähwiler B. H. Vasopressin excites hippocampal neurones. Nature. 1982 Apr 22;296(5859):749–751. doi: 10.1038/296749a0. [DOI] [PubMed] [Google Scholar]
  18. Nicoll R. A., Barker J. L. The pharmacology of recurrent inhibition in the supraoptic neurosecretory system. Brain Res. 1971 Dec 24;35(2):501–511. doi: 10.1016/0006-8993(71)90491-4. [DOI] [PubMed] [Google Scholar]
  19. Pearlmutter A. F., Costantini M. G., Loeser B. Characterization of 3H-AVP binding sites in particulate preparations of rat brain. Peptides. 1983 May-Jun;4(3):335–341. doi: 10.1016/0196-9781(83)90144-4. [DOI] [PubMed] [Google Scholar]
  20. Rivier C., Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature. 1983 Sep 22;305(5932):325–327. doi: 10.1038/305325a0. [DOI] [PubMed] [Google Scholar]
  21. Rossor M. N., Iversen L. L., Hawthorn J., Ang V. T., Jenkins J. S. Extrahypothalamic vasopressin in human brain. Brain Res. 1981 Jun 15;214(2):349–355. doi: 10.1016/0006-8993(81)91199-9. [DOI] [PubMed] [Google Scholar]
  22. Schiffrin E. L., Genest J. 3H-vasopressin binding to the rat mesenteric artery. Endocrinology. 1983 Jul;113(1):409–411. doi: 10.1210/endo-113-1-409. [DOI] [PubMed] [Google Scholar]
  23. Silverman A. J., Hoffman D. L., Zimmerman E. A. The descending afferent connections of the paraventricular nucleus of the hypothalamus (PVN). Brain Res Bull. 1981 Jan;6(1):47–61. doi: 10.1016/s0361-9230(81)80068-8. [DOI] [PubMed] [Google Scholar]
  24. Sofroniew M. V., Weindl A., Schinko I., Wetzstein R. The distribution of vasopressin-, oxytocin-, and neurophysin-producing neurons in the guinea pig brain. I. The classical hypothalamo-neurophypophyseal system. Cell Tissue Res. 1979 Feb 28;196(3):367–384. doi: 10.1007/BF00234734. [DOI] [PubMed] [Google Scholar]
  25. Van Leeuwen F. W., Wolters P. Light microscopic autoradiographic localization of [3H]arginine-vasopressin binding sites in the rat brain and kidney. Neurosci Lett. 1983 Oct 31;41(1-2):61–66. doi: 10.1016/0304-3940(83)90223-9. [DOI] [PubMed] [Google Scholar]
  26. Versteeg C. A., De Jong W., Bohus B. Arginine-vasopressin inhibits centrally induced pressor responses by involving hippocampal mechanisms. Brain Res. 1984 Feb 6;292(2):317–326. doi: 10.1016/0006-8993(84)90767-4. [DOI] [PubMed] [Google Scholar]
  27. Versteeg D. H., De Kloet E. R., Greidanus T. V., De Wied D. Vasopressin modulates the activity of catecholamine containing neurons in specific brain regions. Neurosci Lett. 1979 Jan;11(1):69–73. doi: 10.1016/0304-3940(79)90058-2. [DOI] [PubMed] [Google Scholar]
  28. Weingartner H., Gold P., Ballenger J. C., Smallberg S. A., Summers R., Rubinow D. R., Post R. M., Goodwin F. K. Effects of vasopressin on human memory functions. Science. 1981 Feb 6;211(4482):601–603. doi: 10.1126/science.7455701. [DOI] [PubMed] [Google Scholar]
  29. Yamamura H. I., Gee K. W., Brinton R. E., Davis T. P., Hadley M., Wamsley J. K. Light microscopic autoradiographic visualization of [3H]-arginine vasopressin binding sites in rat brain. Life Sci. 1983 Apr 18;32(16):1919–1924. doi: 10.1016/0024-3205(83)90072-3. [DOI] [PubMed] [Google Scholar]
  30. Zimmerman E. A., Carmel P. W., Husain M. K., Ferin M., Tannenbaum M., Frantz A. G., Robinson A. G. Vasopressin and neurophysin: high concentrations in monkey hypophyseal portal blood. Science. 1973 Nov 20;182(4115):925–927. doi: 10.1126/science.182.4115.925. [DOI] [PubMed] [Google Scholar]
  31. van Leeuwen F., Caffé R. Vasopressin-immunoreactive cell bodies in the bed nucleus of the stria terminalis of the rat. Cell Tissue Res. 1983;228(3):525–534. doi: 10.1007/BF00211473. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES